The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 338:1657-1662 June 4, 1998 Number 23
NextNext

Decreased Epinephrine Responses to Hypoglycemia during Sleep
Timothy W. Jones, M.B., B.S., Paul Porter, M.B., B.S., Robert S. Sherwin, M.D., Elizabeth A. Davis, M.B., B.S., Peter O'Leary, Ph.D., Fiona Frazer, M.B., B.S., Geoffrey Byrne, M.B., B.S., Stephen Stick, M.B., B.S., and William V. Tamborlane, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background In patients with type I diabetes mellitus, hypoglycemia occurs commonly during sleep and is frequently asymptomatic. This raises the question of whether sleep is associated with reduced counterregulatory-hormone responses to hypoglycemia.

Methods We studied the counterregulatory-hormone responses to insulin-induced hypoglycemia in eight adolescent patients with type I diabetes and six age-matched normal subjects when they were awake during the day, asleep at night, and awake at night. In each study, the plasma glucose concentration was stabilized for 60 minutes at approximately 100 mg per deciliter (5.6 mmol per liter) and then reduced to 50 mg per deciliter (2.8 mmol per liter) and maintained at that concentration for 40 minutes. Plasma free insulin, epinephrine, norepinephrine, cortisol, and growth hormone were measured frequently during each study. Sleep was monitored by polysomnography.

Results The plasma glucose and free insulin concentrations were similar in both groups during all studies. During the studies when the subjects were asleep, no one was awakened during the hypoglycemic phase, but during the final 30 minutes of the studies when the subjects were awake both the patients with diabetes and the normal subjects had symptoms of hypoglycemia. In the patients with diabetes, plasma epinephrine responses to hypoglycemia were blunted when they were asleep (mean [±SE] peak plasma epinephrine concentration, 70±14 pg per milliliter [382±76 pmol per liter]; P=0.3 for the comparison with base line), as compared with when they were awake during the day or night (238±39 pg per milliliter [1299±213 pmol per liter], P=0.004 for the comparison with base line, and 296±60 pg per milliliter [1616±327 pmol per liter], P=0.004, respectively). The patients' plasma norepinephrine responses were also reduced during sleep, whereas their plasma cortisol concentrations did not increase and their plasma growth hormone concentrations increased slightly. The patterns of counterregulatory-hormone responses in the normal subjects were similar.

Conclusions Sleep impairs counterregulatory-hormone responses to hypoglycemia in patients with diabetes and normal subjects.


Source Information

From the Departments of Diabetes and Endocrinology and Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Australia (T.W.J., P.P., E.A.D., P.O., F.F., G.B., S.S.); and the Departments of Pediatrics and Internal Medicine, Yale University School of Medicine, New Haven, Conn. (R.S.S., W.V.T.).

Address reprint requests to Dr. Jones at the Department of Diabetes and Endocrinology, Princess Margaret Hospital for Children, Box D184, Perth, WA 6001, Australia.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.